From proactive investors
Zelira Therapeutics and Levin Health talk upcoming chronic pain clinical trialZelira Therapeutics Ltd's (ASX:ZLD) (OTCMKTS:ZLDAF) Dr Oludare Odumosu and Levin Health Limited's Mark Brayshaw discuss plans for its upcoming chronic pain clinical trial. Levin will use Zelira's ZTL-106 formulation for testing on retired athletes in a chronic pain treatment study at La Trobe University in Melbourne. The trial will be sponsored by Levin, which will pay Zelira to design and manage the study, while both companies will share any commercialisation profits.
- Forums
- ASX - By Stock
- Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
From proactive investors Zelira Therapeutics and Levin Health...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
63.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.148M |
Open | High | Low | Value | Volume |
63.0¢ | 63.0¢ | 63.0¢ | $636 | 1.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1190 | 63.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
73.0¢ | 4489 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1190 | 0.630 |
2 | 5830 | 0.610 |
4 | 5415 | 0.600 |
1 | 8000 | 0.580 |
1 | 1200 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.730 | 4489 | 3 |
0.760 | 3933 | 1 |
0.930 | 6000 | 1 |
0.940 | 41387 | 3 |
1.000 | 17106 | 2 |
Last trade - 13.56pm 26/07/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |